TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
RGC

Regencell Bioscience Holdings Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

6.30$ +1.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

Tick rows to compare them in a chart (up to 4)

Income Statement RGC
Line item Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q3 25 Q1 26
-179.97 – – – – – – – – – – –
0.05 – – 0.00 0.00 – – – – – – 0.00
-180.02 – – 0.00 0.00 – – – – – – 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 –
0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
0.00 -0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01
0.00 -0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01
0.00 0.00 0.00 0.00 0.00 0.00 – – 0.00 – – –
0.00 -0.01 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01
-0.13 -0.01 -0.11 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?